Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer
– Toripalimab plus chemotherapy met primary endpoint with significant improvement in PFS compared to chemotherapy…
O2 and Mavenir successfully trial technology to improve call clarity for people with hearing loss